Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

计划入组 30 人 · 首次发布于 2009 年 7 月 29 日

Optimization of clinical regimen of traditional Chinese medicine therapy for Parkinson's disease based on AMPK/SIRT3/GSK3ß /LC3 signaling pathway

GSK3A siRNA(Alnylam Pharmaceuticals)

ROCK, GSK3 and MEK pathway inhibitors (Fate Therapeutics)

Yale Study Reveals GSK3β Inhibitors as Promising Treatment for Relapsed B-Cell Acute Lymphoblastic Leukemia

AMO Pharma Launches Largest-Ever Clinical Trial for Rare Heart Condition ARVC with GSK3β Inhibitor AMO-02

Alkannin Shows Promise in Esophageal Cancer Treatment by Targeting GSK3β